INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 124 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $580,000 | +187.1% | 125,832 | +118.3% | 0.00% | – |
Q4 2018 | $202,000 | -70.6% | 57,644 | -15.5% | 0.00% | – |
Q3 2018 | $688,000 | +14.5% | 68,244 | -17.8% | 0.00% | – |
Q2 2018 | $601,000 | +32.1% | 82,996 | +10.1% | 0.00% | – |
Q1 2018 | $455,000 | -48.8% | 75,406 | -18.3% | 0.00% | – |
Q4 2017 | $888,000 | -44.7% | 92,250 | -49.0% | 0.00% | – |
Q3 2017 | $1,607,000 | -7.1% | 180,907 | +32.2% | 0.00% | -100.0% |
Q2 2017 | $1,730,000 | -38.7% | 136,792 | -49.1% | 0.00% | – |
Q1 2017 | $2,824,000 | +7.4% | 268,752 | -6.0% | 0.00% | – |
Q4 2016 | $2,630,000 | +42.2% | 285,948 | +82.3% | 0.00% | -100.0% |
Q3 2016 | $1,850,000 | +18.4% | 156,892 | +29.9% | 0.00% | 0.0% |
Q2 2016 | $1,562,000 | -47.3% | 120,736 | -34.9% | 0.00% | 0.0% |
Q1 2016 | $2,962,000 | -27.8% | 185,328 | +29.3% | 0.00% | 0.0% |
Q4 2015 | $4,105,000 | -21.5% | 143,386 | -22.0% | 0.00% | -50.0% |
Q3 2015 | $5,232,000 | +165.2% | 183,781 | +234.7% | 0.00% | +100.0% |
Q2 2015 | $1,973,000 | -57.9% | 54,910 | -31.8% | 0.00% | -50.0% |
Q1 2015 | $4,681,000 | -59.9% | 80,524 | -70.9% | 0.00% | -50.0% |
Q4 2014 | $11,660,000 | +533.7% | 276,574 | +482.8% | 0.00% | +300.0% |
Q3 2014 | $1,840,000 | -63.1% | 47,460 | -70.2% | 0.00% | -50.0% |
Q2 2014 | $4,980,000 | -42.1% | 159,460 | -23.2% | 0.00% | -50.0% |
Q1 2014 | $8,599,000 | +9.5% | 207,522 | +2.3% | 0.00% | +33.3% |
Q4 2013 | $7,851,000 | +53.8% | 202,808 | +39.0% | 0.00% | +50.0% |
Q3 2013 | $5,104,000 | +2199.1% | 145,871 | +808.3% | 0.00% | – |
Q2 2013 | $222,000 | – | 16,059 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |